| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
7,186 |
6,581 |
$383K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
4,706 |
4,237 |
$353K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,927 |
1,922 |
$132K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
3,500 |
3,010 |
$119K |
| 99215 |
Prolong outpt/office vis |
827 |
766 |
$90K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
1,438 |
1,438 |
$65K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
132 |
131 |
$12K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,457 |
1,267 |
$12K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
646 |
637 |
$8K |
| 99201 |
|
223 |
223 |
$6K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
379 |
214 |
$4K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
986 |
886 |
$2K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
20 |
20 |
$809.04 |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
67 |
65 |
$733.21 |
| 81002 |
|
257 |
250 |
$664.92 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
110 |
104 |
$417.00 |
| 99417 |
Prolong home eval add 15m |
14 |
13 |
$283.03 |
| 80306 |
|
17 |
17 |
$183.55 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
49 |
47 |
$58.45 |